Craig A. Erickson, M.D., Naomi B. Swiezy, Ph.D., Kimberly A. Stigler, M.D., Christopher J. McDougle, M.D., and David J. Posey, M.D.
Dr. Posey is associate professor of psychiatry at the Indiana University School of Medicine and chief of CSATC.
References
Anderson LT, Campbell M, Grego DM (1984), Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry 141(10):1195-1202.
Briesmeister JM, Schaefer CE (1998), Handbook of Parent Training: Parents as Co-Therapists for Children's Behavioral Problems. New York: Wiley.
Campbell M, Armenteros JL, Malone RP et al. (1997), Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry 36(6):835-843.
Erickson CA, Stigler KA, Posey DJ et al. (in press), Psychopharmacology. In: Autism and Pervasive Developmental Disorders, Volkmar F, ed. New York: Cambridge University Press.
Gordon CT, State RC, Nelson JF et al. (1993), A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 50(6):441-447.
Hagopian LP, Wilson DM, Wilder DA (2001), Assessment and treatment of problem behavior maintained by escape from attention and access to tangible items. J Appl Behav Anal 34(2):229-232.
